Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
The Victorian government’s decision to reject a second Melbourne injecting room earlier this year provoked a polarised public debate, but one voice was largely missing in the media coverage.
An editorial team from the International Journal of Drug Policy has developed guiding principles to help researchers and academics avoid perpetuating stigma when writing about substance use.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
New research reveals how water containing the antidepressant Prozac affects male guppies, raising concerns about the health of aquatic ecosystems exposed to pharmaceutical pollution.
Australia has just listed Indigenous knowledge among its science priorities – after First Nations knowledge has long gone uncredited in Western “discoveries”, such as life-changing drugs.
In a world first, researchers are harnessing data science to describe and predict when resistance to antibiotics will emerge during treatment for a bacterial infection.
Research shows an improved chance of surviving ICU when patients are cared for in units with more than 75% qualified ICU nursing staff, but there’s a desperate shortage of them.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Data from the Australian Institute of Criminology shows alarmingly high rates of sexual violence perpetration.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia, so now’s the time to implement policies to reduce their harm and limit their uptake.
Stigma within the healthcare system is being tackled head-on with the development of resources to help people with substance dependence access the care they need.
Some women who use drugs like Ozempic have reported unexpected pregnancies. What’s going on?
Researchers have completed Australia’s most detailed analysis of opioid tapering trajectories to date, with some findings that contradict current guidelines.
Getting enough quality sleep is important for good health and wellbeing, but sleep problems plague many people with diabetes.
With the the psychedelic field dynamic and rapidly changing, Monash’s pioneering Clinical Psychedelic Lab has a vision to make a meaningful difference in mental healthcare.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
The groundbreaking identification of a specific T-cell receptor in healthy people without lupus has the potential to treat not only that disease, but approximately 100 autoimmune diseases known to have a similar pathology.
With sperm counts declining worldwide, it’s important men know how to keep their sperm as healthy as possible.
Methotrexate is commonly used in Australia and around the world for conditions such as rheumatoid arthritis.
When Monash’s Associate Professor Jun Yang started investigating a little-known but sometimes fatal condition, she could never have imagined the very personal way it would enter her life.
Antibiotics have been around for less than a century. But as resistant bacteria become increasingly difficult to treat, we risk a greater number of deaths from infections.
A new five-year study aims to build a broad picture of illicit drug use in regional Victoria, to better-understand the gaps in local health service planning.
Dummy text
